AURORA HEALTH CARE METRO INC.
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.6M
- Transactions
- 659
- Companies
- 40
- Average per transaction
- $5,397
Who reported the payments
| Medtronic | $1,965,802 |
| Pfizer | $489,440 |
| Cardiofocus, Inc. | $300,000 |
| Amgen | $241,042 |
| W. L. Gore & Associates, Inc. | $176,004 |
| Seagen Inc. | $82,779 |
| National Marrow Donor Program | $39,965 |
| AstraZeneca | $31,000 |
| Stryker | $20,721 |
| Philips North America LLC | $20,394 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19,000 |
| Merck | $15,600 |
| Johnson & Johnson | $14,950 |
| Tesaro, Inc. | $14,854 |
| Siemens Medical Solutions USA, Inc. | $12,880 |
| Abbott | $11,513 |
| Genentech USA, Inc. | $10,000 |
| Angiodynamics, Inc. | $9,917 |
| Bayer | $9,000 |
| Medline Industries LP | $7,500 |
| Linvatec Corporation | $6,567 |
| Zimmer Biomet | $5,986 |
| Novartis | $5,900 |
| Pharmacyclics LLC, An Abbvie Company | $5,200 |
| Boston Scientific | $5,000 |
| Exelixis Inc. | $4,500 |
| AMAG Pharmaceuticals, Inc. | $4,400 |
| Lilly USA, LLC | $4,000 |
| Sanofi | $3,500 |
| Astellas Pharma US Inc | $3,500 |
| Lantheus Medical Imaging, Inc. | $3,000 |
| Bard Peripheral Vascular, Inc. | $2,500 |
| Ipsen Biopharmaceuticals, Inc | $2,000 |
| Verastem, Inc. | $2,000 |
| Smith+Nephew | $1,908 |
| Incyte Corporation | $1,500 |
| Epizyme, Inc. | $1,000 |
| Eli Lilly | $846 |
| BD | $474 |
| Sanofi Pasteur Inc. | $400 |